Development and Evaluation of an Immunoglobulin Y-Based ELISA for Measuring Prostate Specific Antigen in Human Serum

키워드

참고문헌 (36)

1. Davis SN, "Pros and cons of prostate cancer screening : associations with screening knowledge and attitudes among urban African American men", J Natl Med Assoc, 102, pp.174~182 (2010)
2. Parker C, "Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up", Ann Oncol, 26(S5), pp.v69~v77 (2015)
3. Sosnowski R, "The limitations of multiparametric magnetic resonance imaging also must be borne in mind", Cent European J Urol, 69, pp.22~23 (2016)
4. Shariat SF, "Screening for prostate cancer in 2007 : The PSA era and its challenges are not over", Eur Urol, 53, pp.457~460 (2008)
5. Catalona WJ, "Prostate cancer screening and determining the appropriate prostate-specific antigen cut-off values", J Natl Compr Canc Netw, 8, pp.265~270 (2010)
6. Polascik TJ, "Prostate specific antigen : a decade of discovery--what we have learned and where we are going", J Urol, 162, pp.293~306 (1999)
7. Balk SP, "Biology of prostate-specific antigen", J Clin Oncol, 21, pp.383~391 (2003)
8. Kumar A, "Expression of pro form of prostate-specific antigen by mammalian cells and its conversion to mature, active form by human kallikrein 2", Cancer Res, 57, pp.3111~3114 (1997)
9. Travis J, "Human alpha-1-antichymotrypsin : purification and properties", Biochemistry, 17, pp.5647~5651 (1978)
10. Lilja H, "Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin", Clin Chem, 37, pp.1618~1625 (1991)
11. Jung K, "Ratio of free or complexed prostate-specific antigen(PSA)to total PSA : which ratio improves differentiation between benign prostatic hyperplasia and prostate cancer", Clin Chem, 46, pp.55~62 (2000)
12. Catalona WJ, "Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease : a prospective multicenter clinical trial", JAMA, 279, pp.1542~1547 (1998)
13. Prcic A, "Actual contribution of free to total PSA ratio in prostate diseases differentiation", Med Arch, 70, pp.288~292 (2016)
14. proPSA and Prostate Health Index(phi)for the detection of prostate cancer : a systematic review and meta-analysis, "Clin Chem Lab Med", 2013, 729~739
15. Loeb S, "The Prostate Health Index : a new test for the detection of prostate cancer", Ther Adv Urol, 6, pp.74~77 (2014)
16. Łupicka-Słowik A, "Generation and application of polyclonal IgY antibodies specific for full-length and nicked prostate-specific antigen", Bioanalysis, 6, pp.3197~3213 (2014)
17. Schiettecatte J, "Advances in immunoassay technology", pp.45~62 (2012), InTech
18. Larsson A, "Chicken antibodies : a tool to avoid interference by human anti-mouse antibodies in ELISA after in vivo treatment with murine monoclonal antibodies", Hybridoma, 11, pp.33~39 (1992)
19. Larsson A, "Chicken antibodies : a tool to avoid interference by complement activation in ELISA", J Immunol Methods, 156, pp.79~83 (1992)
20. Wang ZQ, "Detection of Trichinella spiralis circulating antigens in serum of experimentally infected mice by an IgY-mAb sandwich ELISA", Foodborne Pathog Dis, 9, pp.727~733 (2012)
21. Leenaars PP, "The production of polyclonal antibodies in laboratory animals. The report and recommendations of ECVAM Workshop 35", Altern Lab Anim, 27, pp.79~102 (1999)
22. Polson A, "Isolation of viral IgY antibodies from yolks of immunized hens", Immunol Commun, 9, pp.475~493 (1980)
23. Łupicka-Słowik A, "Development of adenosine deaminase-specific IgY antibodies : Diagnostic and inhibitory application", Appl Biochem Biotechnol, 184, pp.1358~1374 (2018)
24. Armbruster DA, "Limit of blank, limit of detection and limit of quantitation", Clin Biochem Rev, 29, pp.S49~S52 (2008)[DOI]
25. Armitage P, "Statistical methods in medical research", pp.187~207 (2002), Blackwell Science
26. Lin LIK, "A Concordance correlation coefficient to evaluate reproducibility", Biometrics, 45, pp.255~268 (1989)
27. Passing H, "A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in Clinical Chemistry, Part 1", Clin Chem Clin Biochem, 21, pp.709~720 (1983)
28. Bland JM, "Measuring agreement in method comparison studies", Stat Methods Med Res, 8, pp.135~160 (1999)
29. Krouwer JS, "A simple, graphical method to evaluate laboratory assays", Eur J Clin Chem Clin Biochem, 33, pp.525~527 (1995)
30. Semjonow A, "The clinical impact of different assays for prostate specific antigen", BJU Int, 86, pp.590~597 (2000)
31. Carsten S, "Interchangeability of measurements of total and free prostate-specific antigen in serum with 5 frequently used assay combinations : an update", Clin Chem, 52, pp.59~64 (2006)
32. Kort SAR, "Comparison of 6 automated assays for total and free prostate-specific antigen with special reference to their reactivity toward the WHO 96", 670 reference preparation, 2006, pp.52, 1568~1574
33. Murthy V, "Clinical impact of prostate specific antigen(PSA)inter-assay variability on management of prostate cancer", Clin Biochem, 49, pp.79~84 (2016)
34. Foj L, "Variability of assay methods for total and free PSA after WHO standardization", Tumor Biol, 35, pp.1867~1873 (2014)
35. Liu LN, "Detection of circulating antigen in serum of mice infected with Trichinella spiralis by an IgY-IgM mAb sandwich ELISA", Exp Parasitol, 133, pp.150~155 (2013)
36. Silva DA, "Heterologous antibodies to evaluate the kinetics of the humoral immune response in dogs experimentally infected with Toxoplasma gondii RH strain", Vet Parasitol, 107, pp.181~195 (2002)

관련 논문AI추천